SPXC vs. CVS
Compare and contrast key facts about SPX Corporation (SPXC) and CVS Health Corporation (CVS).
Performance
SPXC vs. CVS - Performance Comparison
Loading graphics...
SPXC vs. CVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SPXC SPX Corporation | -0.06% | 37.48% | 44.06% | 53.86% | 10.00% | 9.42% | 7.19% | 81.65% | -10.77% | 32.34% |
CVS CVS Health Corporation | -8.76% | 84.35% | -40.77% | -12.53% | -7.63% | 54.87% | -5.14% | 17.26% | -7.04% | -5.75% |
Fundamentals
SPXC:
$9.70B
CVS:
$91.71B
SPXC:
$5.05
CVS:
$1.39
SPXC:
39.56
CVS:
51.67
SPXC:
4.26
CVS:
0.23
SPXC:
4.33
CVS:
1.22
SPXC:
$2.27B
CVS:
$402.07B
SPXC:
$917.70M
CVS:
$55.36B
SPXC:
$441.20M
CVS:
$8.69B
Returns By Period
In the year-to-date period, SPXC achieves a -0.06% return, which is significantly higher than CVS's -8.76% return. Over the past 10 years, SPXC has outperformed CVS with an annualized return of 29.18%, while CVS has yielded a comparatively lower -0.76% annualized return.
SPXC
- 1D
- 4.84%
- 1M
- -11.90%
- YTD
- -0.06%
- 6M
- 7.05%
- 1Y
- 55.26%
- 3Y*
- 41.49%
- 5Y*
- 27.41%
- 10Y*
- 29.18%
CVS
- 1D
- 2.40%
- 1M
- -10.11%
- YTD
- -8.76%
- 6M
- -3.17%
- 1Y
- 10.05%
- 3Y*
- 2.77%
- 5Y*
- 2.63%
- 10Y*
- -0.76%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SPXC vs. CVS — Risk / Return Rank
SPXC
CVS
SPXC vs. CVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPX Corporation (SPXC) and CVS Health Corporation (CVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SPXC | CVS | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.51 | 0.33 | +1.18 |
Sortino ratioReturn per unit of downside risk | 2.22 | 0.60 | +1.62 |
Omega ratioGain probability vs. loss probability | 1.28 | 1.09 | +0.19 |
Calmar ratioReturn relative to maximum drawdown | 2.35 | 0.67 | +1.68 |
Martin ratioReturn relative to average drawdown | 7.50 | 1.66 | +5.84 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| SPXC | CVS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.51 | 0.33 | +1.18 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.80 | 0.09 | +0.71 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.78 | -0.03 | +0.81 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.23 | 0.31 | -0.08 |
Correlation
The correlation between SPXC and CVS is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
SPXC vs. CVS - Dividend Comparison
SPXC has not paid dividends to shareholders, while CVS's dividend yield for the trailing twelve months is around 3.70%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SPXC SPX Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 8.04% |
CVS CVS Health Corporation | 3.70% | 3.35% | 5.93% | 3.06% | 2.36% | 1.94% | 2.93% | 2.69% | 3.05% | 2.76% | 2.15% | 1.43% |
Drawdowns
SPXC vs. CVS - Drawdown Comparison
The maximum SPXC drawdown since its inception was -93.77%, which is greater than CVS's maximum drawdown of -64.07%. Use the drawdown chart below to compare losses from any high point for SPXC and CVS.
Loading graphics...
Drawdown Indicators
| SPXC | CVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.77% | -64.07% | -29.70% |
Max Drawdown (1Y)Largest decline over 1 year | -23.15% | -16.44% | -6.71% |
Max Drawdown (5Y)Largest decline over 5 years | -38.32% | -56.79% | +18.47% |
Max Drawdown (10Y)Largest decline over 10 years | -50.26% | -56.79% | +6.53% |
Current DrawdownCurrent decline from peak | -17.73% | -25.47% | +7.74% |
Average DrawdownAverage peak-to-trough decline | -38.39% | -19.59% | -18.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.26% | 6.66% | +0.60% |
Volatility
SPXC vs. CVS - Volatility Comparison
SPX Corporation (SPXC) has a higher volatility of 14.43% compared to CVS Health Corporation (CVS) at 5.98%. This indicates that SPXC's price experiences larger fluctuations and is considered to be riskier than CVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| SPXC | CVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.43% | 5.98% | +8.45% |
Volatility (6M)Calculated over the trailing 6-month period | 27.27% | 23.03% | +4.24% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.80% | 30.81% | +5.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 34.53% | 29.36% | +5.17% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.33% | 28.93% | +8.40% |
Financials
SPXC vs. CVS - Financials Comparison
This section allows you to compare key financial metrics between SPX Corporation and CVS Health Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SPXC vs. CVS - Profitability Comparison
SPXC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, SPX Corporation reported a gross profit of 278.00M and revenue of 637.30M. Therefore, the gross margin over that period was 43.6%.
CVS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, CVS Health Corporation reported a gross profit of 13.57B and revenue of 105.69B. Therefore, the gross margin over that period was 12.8%.
SPXC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, SPX Corporation reported an operating income of 100.10M and revenue of 637.30M, resulting in an operating margin of 15.7%.
CVS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, CVS Health Corporation reported an operating income of 2.11B and revenue of 105.69B, resulting in an operating margin of 2.0%.
SPXC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, SPX Corporation reported a net income of 77.50M and revenue of 637.30M, resulting in a net margin of 12.2%.
CVS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, CVS Health Corporation reported a net income of 2.94B and revenue of 105.69B, resulting in a net margin of 2.8%.